Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

8,823 evidence items · page 117 / 353

35.5 %The proportion of children aged 6–59 months in Nigeria with malaria fever positive as assessed by rapid diagnostic tests was 35.5%.

Nigeriapaludismeobserved 2018published 2021International journal of environmental research and public healthPubMeddocument of 6 observations

3.41 aORBeing a survivor of non-intimate partner sexual violence was significantly associated with three times higher odds of vaccine hesitancy (adjusted odds ratio 3.41).

Nigeriagender-based violenceobserved 2021published 2022African journal of AIDS research : AJARPubMeddocument of 8 observations

29.5 %29.5% of the respondents had good knowledge of breast and cervical cancers and screening.

Nigeriabreast and cervical cancersobserved 2018published 2023PloS onePubMeddocument of 14 observations

34.4 %34.4% of tuberculosis patients were assigned incorrect treatment outcomes by healthcare workers in Lagos private DOTS facilities.

Nigeriatuberculoseobserved 2016published 2022Frontiers in public healthPubMeddocument of 11 observations

15.5 %A weighted HIV prevalence of 15.5% was found among female sex workers in Nigeria.

NigeriaVIH/sidaobserved 2020published 2025Sexually transmitted infectionsPubMeddocument of 12 observations

98.2 %The test efficiency of SickleSCAN™ for sickle cell disease (Hb SS and Hb SC) was 98.2%.

Nigeriadrépanocytosepublished 2017Hemoglobineurope_pmcdocument of 5 observations

16.3 %The prevalence of depression among people living with HIV in two rural secondary health facilities providing antiretroviral therapy services in Southwestern Nigeria was 16.3% between September and December 2020.

Nigeriadépression · VIH/sidaobserved September and December 2020published 2023AIDS research and therapyPubMeddocument of 8 observations

2,000 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for premium ART services was NGN2,000 (USD $5.56), with an interquartile range of NGN1,000–NGN3,000.

NigeriaVIH/sidaobserved July and August 2019published 2023PloS onePubMeddocument of 9 observations

1,250 sexual_contacts1,250 sexual contacts were elicited using the elicitation box model.

NigeriaVIH/sidaobserved Between March 2021 and April 2022published 2024Global health, science and practicePubMeddocument of 8 observations

28.5 %Generalized obesity was present in 28.5% of participants with kidney dysfunction.

Nigeriakidney dysfunctionpublished 2024West African journal of medicinePubMeddocument of 14 observations

14.2 pointsThe health education intervention yielded a net gain of 14.2 points in knowledge about cervical cancer screening among adult women in Cross River State, Nigeria.

Nigeriacancer du col de l'utéruspublished 2023African journal of reproductive healthPubMeddocument of 4 observations

1.6 yearsThe median participant follow-up was 1.6 years.

Nigeriadrépanocytosepublished 2023BloodPubMeddocument of 8 observations

29 cases29 out of 507 mothers living with HIV were informed about the HPV vaccine.

Nigeriainfection à HPVpublished 2026BMC public healthPubMeddocument of 8 observations

53.9 %The prevalence of any ocular disorder among persons living with HIV/AIDS in Osun State, Nigeria was 53.9%.

NigeriaVIH/sidapublished 2026BMC ophthalmologyPubMeddocument of 9 observations

87.5 %87.5% of female sex workers in Kano State, Nigeria, cited desire to know and confirm HIV status as the primary driver for willingness to use HIV services.

NigeriaVIH/sidaobserved 2023published 2025PloS onePubMeddocument of 7 observations

60 %Acute demyelinating encephalomyelitis (ADEM) accounted for 60% (n = 6) of the 10 demyelinating disorder cases in the study population.

NigeriaAcute demyelinating encephalomyelitis (ADEM)observed January 2018 to December 2022published 2024Nigerian journal of clinical practicePubMeddocument of 7 observations

99.7 %Le nitrate de déshydrocorydaline inhibe la croissance de la souche 3D7 de Plasmodium falciparum à 99,7 % avec une concentration inhibitrice 50 (IC50) de 38 nM.

Nigeriapaludisme · souche 3D7observed 2018HAL · Unilimdocument of 173 observations

25 %Recent screening-based studies suggest a β-thalassaemia trait prevalence of up to 25% among individuals without sickle cell disease (SCD) in Africa.

Nigeriadrépanocytose · β-thalassaemiapublished 2026African journal of laboratory medicineeurope_pmcdocument of 5 observations

10 %Clinical pes anserinus tendinitis bursitis syndrome (PATBS) was diagnosed exclusively in 8 female T2DM patients, constituting 10.0% of the total T2DM group.

Nigeriapes anserinus tendinitis bursitis syndrome · type 2 diabetic mellituspublished 2025West African journal of medicinePubMeddocument of 5 observations

3.82 ORSexual minority adolescents with unknown HIV status had significantly higher odds of depressive symptoms (adjusted OR: 3.82; 95% CI: 2.78 to 5.27; p<0.001).

Nigeriadepressive symptomspublished 2022BMJ global healthPubMeddocument of 8 observations

5.7 %Protective efficacy (PE) estimates of PMC with three doses at 80% coverage ranged from 5.7% to 8.8% for clinical malaria in children under two years of age.

Nigeriapaludismepublished 2023Malaria journalPubMeddocument of 6 observations

52.7 %Among 150 seronegative participants, 79 (52.7%) had at least one gastrointestinal parasitic infection.

Nigeriagastrointestinal parasitic infectionspublished 2019Annals of global healthPubMeddocument of 10 observations

30.1 %Sixty-five (30.1%) of 216 inmates were transferred-out without evaluation during TB treatment.

Nigeriatuberculoseobserved 2014–2018published 2022PloS onePubMeddocument of 11 observations

70.8 %Awareness of cervical cancer was 70.8% among women of a Catholic Parish in Nsukka Local Government Area of Enugu State, Nigeria.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

2.13 AORAge less than or equal to 2 years was an independent risk factor for delay in parasite clearance (Adjusted odds ratio = 2.13, 95% confidence interval 1.44–3.15).

Nigeriapaludismeobserved 1996–2008published 2010Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/1475-2875-9-53

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.